CHAMGAP
VERIFIEDPassed the Codex final verification and publication gate. Evidence-verification cutoff: 2026-08-07. AI was used for research and drafting; the existence of all 2 cited sources was verified at the original page, followed by blind grading, adversarial audit, and build validation. Methodology v1.0.
Verdict No. 2413 · Search date 2026-08-07 · Methodology v1.0

Selenium sulfide 2.5% shampoo,
does it really help with Dandruff reduction?

30-Second Summary
C
Evidence Grade C · 50 · Safety caution
Selenium sulfide 2.5% beat vehicle in one short industry-supported trial.
Scalp irritation, itching, odor, and hair or scalp discoloration may occur. Avoid eye contact and use on damaged skin, rinse thoroughly, and stop if marked irritation develops.
What the
research shows
The grade is C with 50 points. In a 246-person double-blind trial, adherent dandruff scores fell 66.7% with 2.5% selenium sulfide and 44.5% with shampoo vehicle. Complete, excellent, or good response occurred in 54.7% versus 28.6% (P=.004), without a reported confidence interval.
What the
ads claim
United States 1% nonprescription and 2.5% prescription formulations differ, and classifications vary by country. Korean pharmacy or supermarket products should be checked for actual ingredient and concentration.
*

Useful facts when choosing a product

  • The pivotal regimen used selenium sulfide 2.5% twice weekly for 29 days.
  • The trial included both ketoconazole 2% active control and shampoo vehicle.
  • The paper states: Supported by Janssen Pharmaceutica Inc.
  • One-percent and 2.5% formulations are not interchangeable evidence.
ID

Chamgap Semantic Classification Code

Candidate index · review held

UNK.selenium-sulfide-2-5-percent-shampoo.UNK.dandruff-reduction.reduce.MULTI

Unknown > Selenium sulfide 2.5% shampoo > Unknown > Dandruff reduction > Reduction claim > Multiple: primary unresolved

An automated migration candidate, not an issued permanent code; exact claim scope remains under review. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.

Download semantic index (JSON) · Codebook v1

Gap Measurement · Verdict 2413 · C 50
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Danby 1993 randomized 246 participants in a 2:2:1 ratio to ketoconazole 2% (97), selenium sulfide 2.5% (100), or shampoo vehicle (49) for 29 days, used twice weekly. Outcomes included adherent and loose dandruff, erythema, itch, yeast, and investigator global improvement. Adherent dandruff fell 66.7% with selenium sulfide and 44.5% with vehicle; global response was 54.7% versus 28.6% (P=.004). Final arm-level absolute scores, variances, confidence intervals, and recurrence were not reported in the accessible article. Ketoconazole was an active comparator. Funding was stated as “Supported by Janssen Pharmaceutica Inc.” Provision of the trial shampoos was not stated.

02

Why this is classified as C (50)

A notable placebo-controlled response is supported by only one short industry-funded trial, limiting the grade to C.

Counterpoint. Ketoconazole shampoo in verdict 710 is B with 64 points because it has a broader placebo-controlled evidence base; this verdict concerns selenium sulfide 2.5%.

Rejudgment record. Cross-check applied — Concentration, comparators, endpoint reporting, and funding were checked against the original trial.

Stored scoring profile
EndpointPSymptom or function itself is the target - including patient reports and performance tests
ReplicationR1Single confirmatory trial
IndependenceI0Evidence comes only from manufacturer studies
Effect sizeE+Meets the clinically important threshold

Stored derived and displayed grades match; this is not a current recalculation or validity check (C).

▦

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Selenium sulfide 2.5% shampoo reduces dandruffCIt beat vehicle, but the claim rests on one 29-day industry-supported trial.
✓

Cross-check — AI research and Codex final gate

AI was used for research and drafting. Blind grading, adversarial audit, and the methodology boundary rules were then reapplied before Codex performed the final evidence, grade, copy, and build checks. If a grade cannot be narrowed, both evidence positions and their reasons are published.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Danby et al. 1993Three-arm double-blind randomized trial246 randomized: ketoconazole 97, selenium sulfide 100, vehicle 49Supported by Janssen Pharmaceutica Inc.Day-29 dandruff scores and investigator global responseAdherent dandruff reduction 66.7% versus 44.5%; response 54.7% versus 28.6%, P=.004Pivotal evidence
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-08-07).

Danby FW, Maddin WS, Margesson LJ, Rosenthal D. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol. 1993;29(6):1008-1012. PMID: 8245236. DOI: 10.1016/0190-9622(93)70282-X.
checked
Okokon EO, Verbeek JH, Ruotsalainen JH, et al. Topical antifungals for seborrhoeic dermatitis. Cochrane Database Syst Rev. 2015;(5):CD008138. PMID: 25933684. PMCID: PMC4448221. DOI: 10.1002/14651858.CD008138.pub3.
checked
Research and draft: AI used · Cross-check: blind grading and adversarial audit
Final verification and publication gate: Codex · Evidence date: 2026-08-07 · Corrections: none
↗

Cite this verdict

Selenium sulfide shampoo × dandruff reduction Evidence Grade C card
[Chamgap] Selenium sulfide shampoo × dandruff reduction — Evidence Grade C·50. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/skin-hair/selenium-sulfide-shampoo-dandruff-reduction/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.
↑